連續性腹膜透析（CAPD）市場規模、佔有率和成長分析：按產品類型、透析方法、患者類型、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024年全球連續性腹膜透析（CAPD）市值為95億美元，預計2025年將成長至100.5億美元，到2033年將成長至157.8億美元。預測期（2026-2033年）的複合年成長率預計為5.8%。

全球持續性攜帶式腹膜透析（CAPD）市場主要受慢性腎臟病率上升和居家照護需求成長的推動。 CAPD使患者能夠全天獨立管理治療，提高生活方式的柔軟性，並最大限度地減少就醫次數，這對於不堪重負的醫療系統至關重要。市場正從手動解決方案轉向先進的液體配方和導管設計，同時整合教育計畫以促進更廣泛的應用。成本控制壓力，加上遠端醫療監測和材料改進等技術創新，透過減少併發症和改善患者預後，推動了CAPD的普及。此外，人工智慧技術透過遠端監測和個人化患者支持，正在革新治療依從性和治療效果，為更積極主動、以患者為中心的護理鋪平道路。

全球持續性腹膜透析（CAPD）市場促進因素

慢性腎臟病盛行率的不斷上升導致需要透析的患者數量顯著增加，從而推動了對便利的居家治療方法（例如持續性腹膜透析 (CAPD)）的需求。隨著醫療保健系統向門診治療轉型，醫護人員和患者都在積極尋求能夠提升自主性並減少對醫療機構依賴的解決方案。這種轉變促使人們增加對訓練、耗材和支援服務的投入，以提高 CAPD 的可近性和接受度。因此，隨著越來越多的患者尋求便利的居家護理，而醫護人員則專注於有效的容量管理和提高護理的連續性，市場持續擴張。

全球持續攜帶式腹膜透析（CAPD）市場面臨的限制因素

全球持續性攜帶式腹膜透析（CAPD）市場面臨嚴峻挑戰，主要原因是居家透析服務和耗材的報銷體係不完善且分散。這種不一致的保險覆蓋範圍為患者和醫療服務提供者都帶來了經濟上的不確定性，導致他們不願意選擇CAPD。除非有可靠的支付管道得到保障，否則醫療服務提供者可能不願投入資源進行必要的培訓和家庭支持，而供應商則面臨著難以預測的市場進入。因此，這種情況阻礙了臨床醫生推薦CAPD和患者的接受度，限制了對服務網路的投資，並阻礙了在各種醫療環境中廣泛應用CAPD所需的基礎設施建設。

全球持續性腹膜透析（CAPD）市場趨勢

全球持續性腹膜透析（CAPD）市場正經歷著向居家護理的顯著轉變，這主要得益於醫療服務提供者和患者對腹膜居家照護的日益青睞，這種透析方式允許患者在傳統醫療機構之外接受治療。這項轉變推動了對病患教育和護理支援計畫的投入，以及對簡化設備設計以提高易用性的努力。支付機構和醫療系統優先考慮的是護理的連續性、減少對住院治療的依賴以及提高患者的生活品質，這促使各方加強合作，旨在最佳化培訓和供應物流。製造商則透過提高耗材的便攜性和便利性、推廣分散式服務模式、增加看護者的參與以及構建以患者為中心的綜合護理路徑來應對這一趨勢，從而將臨床結果與以患者為中心的理念相結合。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球連續性腹膜透析（CAPD）市場規模：依產品類型及複合年成長率（2026-2033）分類

• CAPD溶液
  • 標準葡萄糖溶液
  • 艾考糊精溶液
  • 胺基酸溶液
• CAPD 設備和配件
  • 導管
  • 轉移裝置
  • 連接器
  • 其他配件

全球連續性腹膜透析（CAPD）市場規模：依透析方法及複合年成長率（2026-2033）分類

• 傳統 CAPD
• 自動中央動脈灌洗液（APD）

全球連續性腹膜透析（CAPD）市場規模：依病患類型及複合年成長率（2026-2033）分類

• 成年患者
• 兒童患者
• 老年患者

全球連續性腹膜透析（CAPD）市場規模：按最終用戶和複合年成長率分類（2026-2033 年）

• 醫院
• 透析中心（獨立機構）
• 居家醫療環境
• 專科診所
• 其他

全球連續性腹膜透析（CAPD）市場規模：依分銷管道及複合年成長率（2026-2033）分類

• 線上
• 離線

全球連續性腹膜透析（CAPD）市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Medtronic plc
• B. Braun Melsungen AG
• CareDX, Inc.
• Terumo Corporation
• 3M Health Care
• Dialysis Clinic, Inc.
• Gambro AB
• Nipro Corporation
• ICU Medical, Inc.
• Sorin Group
• NxStage Medical, Inc.
• Asahi Kasei Medical Co., Ltd.
• DaVita Inc.
• Abbot Laboratories
• Polymedicure Inc.
• Medline Industries, Inc.
• Renal Services Group
• Fresenius Kabi AG

結論與建議

Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market size was valued at USD 9.5 Billion in 2024 and is poised to grow from USD 10.05 Billion in 2025 to USD 15.78 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global market for Continuous Ambulatory Peritoneal Dialysis (CAPD) is significantly influenced by the increasing prevalence of chronic kidney disease and the growing preference for home-based therapies. CAPD enables patients to manage their treatment independently throughout the day, enhancing lifestyle flexibility and minimizing hospital visits, which is crucial for overloaded healthcare systems. The market has transitioned from manual solutions to advanced fluid formulations and catheter designs while integrating educational programs to facilitate broader access. Cost containment pressures coupled with technological innovations, such as telehealth monitoring and improved materials, support CAPD's adoption by reducing complications and enhancing patient outcomes. Furthermore, AI technologies are revolutionizing adherence and outcomes through remote monitoring and personalized patient support, paving the way for more proactive, patient-centered care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market Segments Analysis

Global continuous ambulatory peritoneal dialysis (capd) market is segmented by product type, dialysis modality, patient type, end users, distribution channel and region. Based on product type, the market is segmented into Capd Solutions and Capd Equipment & Accessories. Based on dialysis modality, the market is segmented into Traditional CAPD and Automated CAPD (APD). Based on patient type, the market is segmented into Adult Patients, Pediatric Patients and Geriatric Patients. Based on end users, the market is segmented into Hospitals, Dialysis Centers (Independent), Home Healthcare Settings, Specialty Clinics and Others. Based on distribution channel, the market is segmented into Online and Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The growing incidence of chronic kidney disease is significantly increasing the number of patients in need of dialysis, which in turn drives demand for convenient, home-based treatment options like continuous ambulatory peritoneal dialysis (CAPD). As healthcare systems move towards outpatient care, both clinicians and patients favor solutions that promote independence and lower reliance on medical facilities. This shift fosters investments in training, supplies, and supportive services to enhance the accessibility and acceptance of CAPD. Consequently, the market experiences expansion as more patients seek the convenience of home treatments, while providers focus on effective capacity management and improving continuity of care.

Restraints in the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The Global Continuous Ambulatory Peritoneal Dialysis (CAPD) market faces significant challenges due to insufficient and fragmented reimbursement systems for home dialysis services and supplies. This lack of consistent coverage creates financial uncertainty for both patients and providers, leading to reluctance in opting for CAPD. Healthcare providers may be unwilling to invest resources into the necessary training and home support without assured payment pathways, while suppliers deal with unpredictable market access. Consequently, this situation hinders clinician recommendations and patient acceptance, limits investment in service networks, and impedes the development of essential infrastructure necessary for the broader adoption of CAPD in various healthcare environments.

Market Trends of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The Global Continuous Ambulatory Peritoneal Dialysis (CAPD) market is witnessing a significant trend towards home-based care, driven by a growing preference among providers and patients for peritoneal dialysis modalities that facilitate treatment outside traditional healthcare settings. This shift is fueling investments in patient education and nursing support programs, along with efforts to simplify device designs for enhanced usability. Payers and health systems are prioritizing continuity of care, reduced hospital dependence, and improved patient quality of life, leading to increased collaborations aimed at optimizing training and supply logistics. Manufacturers are responding by enhancing the portability and convenience of consumables, thus promoting decentralized delivery models, bolstering caregiver engagement, and fostering integrated care pathways that align clinical outcomes with a patient-centered approach.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Capd Solutions
  • Standard Dextrose Solutions
  • Icodextrin Solutions
  • Amino Acid Solutions
• Capd Equipment & Accessories
  • Catheters
  • Transfer Sets
  • Connectors
  • Other Accessories

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Dialysis Modality & CAGR (2026-2033)

• Market Overview
• Traditional CAPD
• Automated CAPD (APD)

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adult Patients
• Pediatric Patients
• Geriatric Patients

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals
• Dialysis Centers (Independent)
• Home Healthcare Settings
• Specialty Clinics
• Others

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Online
• Offline

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size & CAGR (2026-2033)

• North America (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDX, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Health Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialysis Clinic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gambro AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NxStage Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbot Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polymedicure Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renal Services Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations